SOURCES SOUGHT
65 -- YELLOW FEVER VACCINE
- Notice Date
- 3/14/2024 12:58:38 PM
- Notice Type
- Sources Sought
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- DLA TROOP SUPPORT PHILADELPHIA PA 19111 USA
- ZIP Code
- 19111
- Solicitation Number
- SPE2DP24Q0084
- Response Due
- 3/18/2024 2:00:00 AM
- Archive Date
- 04/02/2024
- Point of Contact
- Shairy M. Cartagena215-737-0730, Phone: 215.737.0730
- E-Mail Address
-
Shairy.Cartagena@dla.mil
(Shairy.Cartagena@dla.mil)
- Description
- The Defense Logistics Agency- Troop Support is seeking sources capable of providing YELLOW FEVER VACCINE, USP, One Vial (Sufficient for 5 Doses). CONTAINS 3ML. UNIT OF ISSUE: ""EACH"" (1 VIAL). REQ REFRIG. BTWN 2-8 DEG. C; SUBJECT TO DAMAGE BY FREEZING. Shelf life is 12 months.� At least 10 months of shelf life shall remain at the time of delivery to the first government activity. DLA Troop Support has a requirement for Yellow Fever Vaccine of 47 Vials.� The vaccine shall be delivered to the Defense Distribution Depot Norfolk, VA, and the desirable delivery time is end of March 2024. This is a request for information (RFI) and does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to the RFI. All submitted information shall remain with the U.S. Government and will not be returned. *** Currently Marketed YELLOW FEVER VACCINE*** If your firm currently markets YELLOW FEVER VACCINE, please provide information with respects to the following: 1.Place of Manufacture 2.FDA registration information 3.Product Name and description including description of any special features 4.Current unit sale price 5.Delivery days for this item and earliest product available time *** New Products Under Development *** For products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or FDA testing/trials etc. Firms and organizations that currently develop or manufacture product described in this RFI or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to DLA Troop Support. Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for Yellow Fever Vaccine.� All information submitted will be kept confidential as allowed by relevant Federal law and will be eligible for additional special protections under the conditions of the Protected Critical Infrastructure Information (PCII) Program outlined in the Critical Infrastructure Information Act of 2002. Your response to this RFI may be submitted electronically in pdf format and emailed to the Contracting Officer shairy.cartagena@dla.mil.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/b33fd3f20f3d459b80f9f7f632cbaed0/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06997983-F 20240316/240314230057 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |